While in pancreatic cancer (PC), SIRT7 regulates GLUT3 expression by binding to its enhancer and modulating H3K122 succinylation, thus influencing gemcitabine sensitivity in PC cells. Here, SLC2A3 is linked to pachyonychia congenita.